EUR 0.08
(-1.89%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 1.55 Million EUR | 554.43% |
2022 | 237 Thousand EUR | 116.39% |
2021 | -1.44 Million EUR | 31.7% |
2020 | -2.11 Million EUR | -211.72% |
2019 | 1.89 Million EUR | 0.91% |
2018 | 1.87 Million EUR | -49.56% |
2017 | 3.72 Million EUR | 223.74% |
2016 | 1.15 Million EUR | -27.22% |
2015 | 1.58 Million EUR | 18.91% |
2014 | 1.32 Million EUR | -41.35% |
2013 | 2.26 Million EUR | 124.22% |
2012 | 1.01 Million EUR | -20.63% |
2011 | 1.27 Million EUR | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | -834 Thousand EUR | 0.0% |
2023 Q4 | 302 Thousand EUR | 0.0% |
2023 Q2 | -1.33 Million EUR | 0.0% |
2023 FY | 1.55 Million EUR | 554.43% |
2022 Q2 | -930.99 Thousand EUR | 0.0% |
2022 FY | 237 Thousand EUR | 116.39% |
2022 Q4 | -2.22 Million EUR | 0.0% |
2021 FY | -1.44 Million EUR | 31.7% |
2021 Q2 | -521 Thousand EUR | 0.0% |
2021 Q4 | -925 Thousand EUR | 0.0% |
2020 Q4 | -645 Thousand EUR | 0.0% |
2020 FY | -2.11 Million EUR | -211.72% |
2020 Q2 | -1.52 Million EUR | 0.0% |
2019 Q2 | 511 Thousand EUR | 0.0% |
2019 Q4 | -33 Thousand EUR | 0.0% |
2019 FY | 1.89 Million EUR | 0.91% |
2018 Q2 | 1.1 Million EUR | 0.0% |
2018 FY | 1.87 Million EUR | -49.56% |
2018 Q4 | 769 Thousand EUR | 0.0% |
2017 Q2 | 2.8 Million EUR | 0.0% |
2017 FY | 3.72 Million EUR | 223.74% |
2017 Q4 | 920 Thousand EUR | 0.0% |
2016 Q2 | 794 Thousand EUR | 0.0% |
2016 FY | 1.15 Million EUR | -27.22% |
2016 Q4 | 356 Thousand EUR | 0.0% |
2015 FY | 1.58 Million EUR | 18.91% |
2015 Q4 | 789.2 Thousand EUR | 0.0% |
2015 Q2 | 790.85 Thousand EUR | 0.0% |
2014 Q4 | 567.95 Thousand EUR | 0.0% |
2014 Q2 | 760.8 Thousand EUR | 0.0% |
2014 FY | 1.32 Million EUR | -41.35% |
2013 FY | 2.26 Million EUR | 124.22% |
2013 Q4 | 1.42 Million EUR | 0.0% |
2013 Q2 | 840.63 Thousand EUR | 0.0% |
2012 Q1 | 452.41 Thousand EUR | 0.0% |
2012 Q2 | 452.41 Thousand EUR | 0.0% |
2012 Q3 | 452.41 Thousand EUR | 0.0% |
2012 Q4 | 566.41 Thousand EUR | 25.2% |
2012 FY | 1.01 Million EUR | -20.63% |
2011 Q3 | 357.54 Thousand EUR | -0.0% |
2011 Q4 | 452.41 Thousand EUR | 26.53% |
2011 FY | 1.27 Million EUR | 0.0% |
2011 Q1 | 357.54 Thousand EUR | -0.0% |
2011 Q2 | 357.54 Thousand EUR | 0.0% |
2010 Q4 | 357.54 Thousand EUR | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Crossject Société Anonyme | -6.13 Million EUR | 125.281% |
Safe Orthopaedics SA | 4.1 Million EUR | 62.226% |
Amplitude Surgical SA | 37.2 Million EUR | 95.831% |
Sartorius Stedim Biotech S.A. | 1.23 Billion EUR | 99.874% |
EssilorLuxottica Société anonyme | 16.07 Billion EUR | 99.99% |
bonyf N.V. | 26.41 Thousand EUR | -5771.886% |